Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Lee

Showing results (421-430 of 594) with videos related to

Pageof 60
Sort By:
Plos One|May 5, 2012
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humansCharles Lu, David J Stewart, J Jack Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Pilot randomized phase II study of celecoxib in oral premalignant lesionsVassiliki A Papadimitrakopoulou, William N William, Andrew J Dannenberg, et al.
Research Square|May 27, 2024
Joint multi-omics discriminant analysis with consistent representation learning using PANDAMuhammad Aminu, Lingzhi Hong, Natalie Vokes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
<i>STK11</i>/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase InhibitionPiyada Sitthideatphaiboon, Ana Galan-Cobo, Marcelo V Negrao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progressionLi-E Wang, Chunying Li, Sara S Strom, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2010
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancerMohammed Taoudi Benchekroun, Pierre Saintigny, Sufi M Thomas, et al.
Molecular Cancer Therapeutics|October 5, 2013
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutationsPrasanth Ganesan, Filip Janku, Aung Naing, et al.
Journal of Immunotherapy and Precision Oncology|April 16, 2025
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021Mehmet Altan, Dawen Sui, Cai Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapyBenjamin J Moeller, John S Yordy, Michelle D Williams, et al.
Cancer|April 19, 2021
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiationTheresa W Guo, Faiez Saiyed, Christopher M K L Yao, et al.
Pageof 60

Showing results (421-430 of 594) with videos related to

Sort By:
Pageof 60
Plos One|May 5, 2012
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humansCharles Lu, David J Stewart, J Jack Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Pilot randomized phase II study of celecoxib in oral premalignant lesionsVassiliki A Papadimitrakopoulou, William N William, Andrew J Dannenberg, et al.
Research Square|May 27, 2024
Joint multi-omics discriminant analysis with consistent representation learning using PANDAMuhammad Aminu, Lingzhi Hong, Natalie Vokes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
<i>STK11</i>/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase InhibitionPiyada Sitthideatphaiboon, Ana Galan-Cobo, Marcelo V Negrao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progressionLi-E Wang, Chunying Li, Sara S Strom, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2010
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancerMohammed Taoudi Benchekroun, Pierre Saintigny, Sufi M Thomas, et al.
Molecular Cancer Therapeutics|October 5, 2013
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutationsPrasanth Ganesan, Filip Janku, Aung Naing, et al.
Journal of Immunotherapy and Precision Oncology|April 16, 2025
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021Mehmet Altan, Dawen Sui, Cai Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapyBenjamin J Moeller, John S Yordy, Michelle D Williams, et al.
Cancer|April 19, 2021
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiationTheresa W Guo, Faiez Saiyed, Christopher M K L Yao, et al.
Pageof 60